FGF受体激酶抑制剂通过向Src家族激酶来表现出广泛的抗病毒活性
Debora Stefanova1, Dominik Olszewski2, Mirco Glitscher3
1Institute of Molecular Health Sciences, Department of Biology, ETH Zürich, Otto-Stern-Weg 7, Zürich, 8093, Switzerland. debora.stefanova@biol.ethz.ch.
Cellular and molecular life sciences : CMLS
|December 2, 2024
概括
纤维细胞生长因子受体 (FGFR) 抑制剂通过阻断早期感染阶段,表现出广泛的抗病毒活性. 这种效应主要通过抑制Src家族激酶,特别是Lyn,而不是FGFR本身来实现.
科学领域:
- 生物医学研究的研究.
- 病毒学 病毒学
- 药物发现 药物发现
背景情况:
- 广泛的抗病毒药物稀缺,阻碍了对各种病毒感染的有效治疗.
- 纤维细胞生长因子受体 (FGFR) 氨酸激酶抑制剂 (TKI) 正在探索其治疗潜力.
研究的目的:
- 研究FGFR抑制剂的广泛抗病毒活性.
- 阐明FGFR抑制剂抗病毒作用的机制.
主要方法:
- 利用了感染DNA和RNA病毒的各种细胞类型.
- 进行RNA分析,以分析基因表达变化.
- 进行了生物信息学分析,向激酶测定,siRNA介导的敲击和药物抑制.
主要成果:
- FGFR抑制剂减少了DNA和RNA病毒的感染,独立于FGFR激酶抑制.
- 抗病毒活性主要归因于Src家族激酶的阻断,特别是Lyn.
- 干扰素反应基因上调与抗病毒疗效没有相关性.
结论:
- FGFR 抑制剂代表了一种新型的宽谱抗病毒药物.
- 向Lyn酶为开发新的抗病毒疗法提供了一个有前途的战略.
相关概念视频
Retrovirus Life Cycles
45.6K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.6K
Rous Sarcoma Virus (RSV) and Cancer
5.0K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.0K
Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
Receptor Tyrosine Kinases
12.3K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
12.3K
Enzyme-linked Receptors
77.3K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
77.3K


